The project will lay the foundation for broader adoption of a core set of quality measures to guide care, accountability, and payment. WASHINGTON, D.C. / ACCESS Newswire / April 21, 2026 / The ...
To operate successfully in a Good Manufacturing Practice (GMP) regulated contract testing environment, an organisation needs ...
The AI-driven platform delivers tumor treatment predictive biomarkers to oncology researchers faster, more accurately, and at scale. MILWAUKEE & NEWTON, Mass.--(BUSINESS WIRE)--#4DPath--Versiti ...
UCB has announced a definitive agreement to acquire Neurona Therapeutics in a deal valued at up to $1.15 billion, ...
MCLEAN, Va.--(BUSINESS WIRE)--Zephyr AI, Inc. (“Zephyr AI”), a leader in precision medicine harnessing artificial intelligence to accelerate drug development, today announced that it has appointed ...
CLEVELAND & DALLAS--(BUSINESS WIRE)--Align Capital Partners’ (“ACP”) portfolio company StenTech (the “Company”), a leading provider of surface mount technology (“SMT”) printing solutions, has ...
Responsible, auditable AI agents redefine quality and compliance operations with human oversight, full transparency and enterprise-grade control Dot Compliance, a provider of AI-powered compliance ...
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced today it has entered into a collaboration with Osmind, the ...
BOSTON--(BUSINESS WIRE)--d-wise (an Instem company), a leader in statistical computing infrastructure and clinical trial transparency, today announced the appointment of Christine Oliver as its ...
GEn1E Lifesciences Inc., a Phase 2 clinical-stage biotechnology company advancing AI-driven novel precision medicines for ...
MedaSystems, the leading SaaS platform for Expanded Access (EA), Post-Trial Access (PTA), and Investigator-Initiated Studies (IIS), today announced a significant new platform release, introducing ...
As demand from sponsors and CROs for proven, large‑scale remote patient monitoring (RPM) capabilities continues to accelerate, AMC Health expands its decentralized clinical trial (DCT) program, ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する